← BackSTERIS plc · Orthopedic, Prosthetic & Surgical Appliances & SuppliesSTE
Low riskNext report: Around Nov 4 (est.)
The short versionA high-quality, profitable business with steady sales.
Going well
- Profitable every year for 10 years
- Brings in more cash than it spends
- Little debt
Money moves
- No insider buying or selling in the last 30 days
- Institutions added 1.4% to their holdings in the quarter ending June 2026 (397 bought, 402 sold)
- Held by Ray Dalio (Bridgewater)
Facts from SEC filings, not a recommendation.
What the price means
Price as of Oct 26
$230.10-0.9% that day
- Company value
- $22.4B
- Share price times all shares
- Price vs profit (P/E)
- 28.7x
- You pay about $29 for each $1 of yearly profit
- Price vs sales
- 3.7x
- Company value is 3.7 times a year of sales
- Dividend yield
- 1.1%
- Yearly dividend as a share of today's price
- Cash vs value
- 2%
- Cash as a share of company value
- Debt vs value
- 8%
- Debt as a share of company value
From STE's last IEX trade and its SEC filings (profits and sales over the last four quarters). A starting point for research, not a verdict.
The business over time
Last 12 quarters, from SEC filings
Sales, Jun '26$1.5B+7.3% vs a year earlier
Sep '23Tap a barJun '26
Last 12 months: $6.0B, up 8.4% from the 12 months before. Over 5 years, sales grew about 14% a year.
Business quality
The checklist Warren Buffett-style investors use. Annual numbers for 2025.- MissReturn on equity 15%+Earns a lot on the money owners have in the business.11.5%
- PassDebt under half of equityNot relying on borrowed money.0.27x equity
- PassNet margin 10%+Keeps at least 10 cents of profit from each dollar of sales.13.2%
- PassProfitable every yearSteady profits, not one good year.10 of 10 years
- PassFree cash flow positiveBrings in more cash than it spends to run and grow.$972.4M
- PassShare count not growingNot diluting owners. Falling means buybacks.-1.5% in 3 years
- PassGross margin 40%+Pricing power: sells for well above what it costs to make.44.2%
- Revenue
- $5.9B
- +8.7% vs prior year
- 5-year growth
- +13.8%/yr
- revenue, per year
- Total debt
- $1.9B
- 0.27x equity
- Current ratio
- 2.48x
- short-term assets / bills due
From annual reports filed with the SEC. A checklist is a starting point for research, not a verdict.
Latest quarter
Quarter ended Jun 30, 2026- Revenue
- $1.5B
- +7.3% YoY
- Op. margin
- 19.1%
- +1.4 pts
- Gross margin
- 45.8%
- +0.7 pts
- Free cash flow
- $279.6M
- Share count
- -0.9%
- vs a year ago
Insider rating
Last 90 days
No open-market insider buys or sells in the last 90 days.
Weekly insider trendNo trades to chart yet.
Filing buzz
Last 7 days vs normal
0/ 100
- This week
- 0
- Normal week
- 1.2
- vs normal
- 0.0x
SEC filings of any kind. 50 means a normal week.
Institutional ownership
■Steady+1.4%Institutions added 1.4% to their holdings. 397 bought, 402 sold. 6 quarters of net buying in a row.
Shares held by institutions95.0M
Sep '24Jun '26
Share count growthYearly rate, last 3 years
-0.4%Cash runwayAt last year's cash burn
Cash flow positiveDebt to equityLatest balance sheet: debt compared with what owners have
0.2x · $1.7B debtShares outstandingLatest reported
98MNext reportAround Nov 4 (est.)Estimated from the same quarter last year
- Results filedAug 5
- Results filedMay 11
- Results filedFeb 4
- Results filedNov 5, 2025
- Results filedAug 6, 2025
Flags and big holders
Offerings 6 months, flags 12 months, holders 90 days
No offerings, red flags or new big holders. Clean record.
Insider trades
Open-market buys and sells, last 90 days
No open-market buys or sells in 90 days. Grants and option exercises are left out.
"Owns after" is the insider's holding right after the trade. Pre-planned (10b5-1) sales are set up months ahead, a weaker signal.
Latest filings
Straight from SEC EDGAR
Shares withheld for taxesKaren L BurtonSr. Vice Pres., CFO
228 shares
- -2% of holdings
- Now owns 12,956 shares
- Filed 4 days after trade
Stock awardEsther M. AlegriaDirector
2,018 shares
- +145% of holdings
- Now owns 3,408 shares
- Exercise price $238.91
- Director Stock Option (right to buy)
- 2 transactions
- Filed 2 days after trade
Stock awardPierre BouludDirector
1,025 shares
- +279% of holdings
- Now owns 1,392 shares
- Career Restricted Stock Units
- Filed 2 days after trade
Stock awardCynthia L FeldmannDirector
2,018 shares
- +30% of holdings
- Now owns 8,640 shares
- Exercise price $238.91
- Director Stock Option (right to buy)
- 2 transactions
- Filed 2 days after trade
Stock awardChristopher S HollandDirector
1,025 shares
- +21% of holdings
- Now owns 5,989 shares
- Career Restricted Stock Units
- Filed 2 days after trade
Stock awardPaul Edward MartinDirector
2,018 shares
- +66% of holdings
- Now owns 5,074 shares
- Exercise price $238.91
- Director Stock Option (right to buy)
- 2 transactions
- Filed 2 days after trade